Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study
Technology in Cancer Research & Treatment · 2026-07 · 25
DOI: 10.1177/15330338261470635 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 31.07.2026. Verfasst von Dewei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Metabolomics, Biomarkers, Tumor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional Collaborative Innovation Special Project - Science and Technology Aid Xinjiang Program, The National Key Clinical Specialty of the People’s Hospital of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
Introduction
Lung cancer is a malignant tumor with high global incidence and mortality. Early screening and diagnosis can substantially extend patient survival, yet achieving this remains a challenging objective.
Methods
We collected tissue and plasma samples from patients with benign pulmonary nodules and non-small cell lung cancer (NSCLC). Exhaled breath condensate (EBC) samples were obtained from these patients using a breath condenser. Differential metabolites were identified in samples from 22 NSCLC patients and 20 benign controls by means of ultra-performance liquid chromatography–high resolution mass spectrometry–based untargeted metabolomics.
Results
Several differential metabolites overlapped between plasma and tissue samples. Further analysis indicated that the differential metabolites from all three sample types participated in central carbon metabolism in cancer, protein digestion and absorption, and aminoacyl-tRNA biosynthesis. ROC curve analysis of plasma and tissue metabolites showed that each of the top 10 upregulated and downregulated metabolites yielded AUC values greater than 0.8. In EBC, only 29 differential metabolites were detected. Among these, lysine, acetildenafil, and 1-(cyclohexylmethyl) proline may be involved in the progression of NSCLC.
Conclusion
This study identified distinctive metabolic markers in plasma, tissue, and EBC from NSCLC patients. However, the purpose of this observational study was merely exploratory, rather than to use these differential metabolites as a diagnostic test for non-small cell lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Clinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
- Department of Thoracic Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
ORCID-Profile: Dewei Li
Förderung
- Regional Collaborative Innovation Special Project - Science and Technology Aid Xinjiang Program
- The National Key Clinical Specialty of the People’s Hospital of Xinjiang Uygur Autonomous Region
Zitieren
APA
Li, D., Yang, S., Zhang, L., Dong, L., Sailai, Y., Yao, L., Jin, C., & Wei, X. (2026). Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261470635
Vancouver
Li D, Yang S, Zhang L, Dong L, Sailai Y, Yao L, et al. Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261470635
BibTeX
@article{Li2026,
author = {Li, Dewei and Yang, Shuting and Zhang, Ling and Dong, Lingling and Sailai, Yueeryeti and Yao, Limin and Jin, Chengyu and Wei, Xuemei},
title = {Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261470635}
}
EUVIMED